Related Experiment Video
Updated: Jun 8, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Insomnia treatments: moving from efficacy to effectiveness
Patricia L Haynes1, Richard R Bootzin
1Department of Psychiatry, The University of Arizona, 1501 N. Campbell Ave., PO Box 245002, Tucson, AZ 85724-5002, USA. thaynes@email.arizona.edu
This special issue addresses insomnia and sleep disturbances, highlighting the need for more trained practitioners. It debunks common myths hindering effective sleep problem treatment.
Area of Science:
- Clinical Psychology
- Sleep Medicine
Background:
- Growing recognition of sleep's importance for health and well-being.
- Shortage of healthcare practitioners experienced in insomnia therapies.
- Prevalence of sleep disturbances across diverse populations.
Purpose of the Study:
- To address the treatment of insomnia and sleep disturbances.
- To identify and refute common myths impeding sleep problem treatment.
- To introduce a special issue focused on insomnia therapies.
Main Methods:
- Literature review and expert consensus on sleep disturbance treatment.
- Identification and refutation of prevalent misconceptions regarding sleep.
- Compilation of research articles on insomnia therapies.
Main Results:
- Common myths that may hinder effective sleep problem treatment have been identified.
- These myths have been systematically refuted.
- A collection of seven articles offering insights into insomnia therapies is presented.
Conclusions:
- Addressing misconceptions is crucial for improving insomnia treatment outcomes.
- Increased practitioner training in sleep therapies is warranted.
- This special issue provides valuable resources for clinicians treating sleep disturbances.
More Related Videos
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
CNS Depressants: Barbiturates and Benzodiazepines
Blind Procedures